Clinical trial tech outfit Medidata has elevated a new strategy leader from within. | Clinical trial tech outfit Medidata has elevated a new strategy leader from within. Industry veteran Lisa ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 study titled Phase 3, ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Swede Vincent Norrman won the last Irish Open at the venue, beating German Hurly Long by one stroke. Five-time major champ ...

In a major boost to Amgen Irish Open organisers, Koepka will be joined by Sergio Garcia and Tyrrell Hatton for this year's ...

The 2025 Amgen Irish Open, returning to The K Club’s Palmer North Course from September 4–7, with the Celebrity Pro-Am teeing ...

Amgen Inc. has witnessed a notable reduction in stock holdings by Donoghue Forlines LLC, slicing 17.6% to stand at 4,656 ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Since 2018, Brown University has hosted dozens of interns through PrepareRI, a statewide initiative that helps high schoolers ...

Amgen Inc. reported a robust quarterly performance, surpassing analyst expectations with a notable revenue increase of 9.4%. ...

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported that the Phase 3 FORTITUDE-101 trial achieved its primary endpoint.